These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3738859)

  • 1. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography.
    Southan C; Thompson E; Lane DA
    Thromb Res; 1986 Jul; 43(2):195-204. PubMed ID: 3738859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
    Southan C; Thompson E; Lane DA
    Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human fibrinopeptides by high-performance liquid chromatography.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of human fibrinopeptides by high-performance liquid chromatography.
    Ebert RF; Bell WR
    Anal Biochem; 1985 Jul; 148(1):70-8. PubMed ID: 4037309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinopeptide-releasing enzymes in the venom from the southern copperhead snake (Agkistrodon contortrix contortrix).
    Dyr JE; Hessel B; Suttnar J; Kornalík F; Blombäck B
    Toxicon; 1989; 27(3):359-73. PubMed ID: 2728027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of bovine fibrinopeptides by high performance liquid chromatography.
    Martinelli RA; Scheraga HA
    Anal Biochem; 1979 Jul; 96(1):246-9. PubMed ID: 495988
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new truncated form and deamidation products of fibrinopeptide B released by thrombin from human fibrinogen.
    Cardinali B; Damonte G; Melone L; Salis A; Tosetti F; Rocco M; Profumo A
    Thromb Haemost; 2006 Sep; 96(3):302-8. PubMed ID: 16953271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
    Ebert RF; Schreiler WE; Bell WR
    Thromb Res; 1986 Jul; 43(1):7-13. PubMed ID: 3726812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of a fibrin-promoting enzyme from the venom of Agkistrodon contortrix contortrix on rat fibrinogen and plasma.
    Dyr JE; Suttnar J; Simák J; Fortová H; Kornalík F
    Toxicon; 1990; 28(11):1364-7. PubMed ID: 2087698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and assay of phosphoserine and tyrosine-O-sulphate in fibrinopeptides by reversed-phase high-performance liquid chromatography.
    Lucas J; Henschen A
    J Chromatogr; 1986 Nov; 369(2):357-64. PubMed ID: 3100570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
    Mullin JL; Gorkun OV; Binnie CG; Lord ST
    J Biol Chem; 2000 Aug; 275(33):25239-46. PubMed ID: 10837485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased phosphorylation of human fibrinopeptide A under acute phase conditions.
    Seydewitz HH; Witt I
    Thromb Res; 1985 Oct; 40(1):29-39. PubMed ID: 4089825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high performance liquid chromatography: investigation of A alpha-chain N-terminal heterogeneity.
    Southan C; Thompson E; Lane DA
    Thromb Haemost; 1986 Oct; 56(2):193-7. PubMed ID: 3643663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay of human fibrinopeptides.
    Butler VP; Nossel HL; Canfield RE
    Methods Enzymol; 1982; 84():102-18. PubMed ID: 7048006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.